Certara Products - Certara IQ Archives | Certara

Video

ADC Development & Differentiation Strategies | Quantitative Systems Pharmacology & MIDD

Learn how model-informed drug development (MIDD) and quantitative systems pharmacology (QSP) support antibody-drug conjugate (ADC)…

Certara2026 年 3 月 13 日

Conference

Discovery & Development Europe 2026

Certara2026 年 3 月 13 日

Webinar

Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access

Danielle Pillsbury2026 年 2 月 23 日

Webinar

Optimal Dosing, Optimal Outcomes: Model-Based Approaches for Antibody–Drug Conjugates (ADCs)

Certara2026 年 2 月 23 日

Webinar

Strong starts, confident finishes: Optimizing first-in-human strategies for antibody–drug conjugates (ADCs)

Certara2026 年 2 月 23 日

On-Demand Webinar

Accelerate Decisions with Certara IQ™: Scalable, AI-Driven QSP for Drug Development

Discover how Certara's AI-powered QSP modeling software, Certara IQ is overcoming challenges in drug development…

Certara2026 年 2 月 17 日

Live Events

Certara IQ^™ Global Roadshow

Certara IQ™ is going on the road. From APAC to Europe to North America, our…

Certara2026 年 2 月 12 日

Live Events

Certara IQ™ Workshop

Certara2026 年 2 月 11 日

Publication

Anti-PD-(L)1 Antibodies: Insights From QSP-Based Meta-Analysis

Anti-PD-1 and anti-PD-L1 antibodies have transformed cancer immunotherapy, yet clinical meta-analyses suggest differences in efficacy…

Certara2026 年 2 月 11 日

Blog

How Quantitative Systems Pharmacology Addresses Key Challenges in Alzheimer’s Drug Development

Quantitative Systems Pharmacology (QSP) helps address key challenges in Alzheimer’s disease drug development, including tau…

Certara2026 年 2 月 2 日

© 2026 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software